SPHERA FUNDS MANAGEMENT LTD. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 106 filers reported holding GW PHARMACEUTICALS PLC in Q2 2015. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2019$8,051,000
-5.4%
77,000
+4.1%
0.66%
-49.6%
Q3 2019$8,512,000
+13.5%
74,000
-3.9%
1.32%
+55.6%
Q4 2018$7,499,000
+82.2%
77,000
+148.4%
0.84%
+26.1%
Q3 2016$4,115,000
+12.3%
31,000
-22.5%
0.67%
-29.5%
Q2 2016$3,663,000
+121.7%
40,000
+68.1%
0.95%
+293.0%
Q4 2015$1,652,000
-58.0%
23,790
-44.8%
0.24%
-51.8%
Q3 2015$3,938,000
-26.3%
43,100
-0.9%
0.50%
-4.0%
Q2 2015$5,344,000
+67.5%
43,500
+24.3%
0.52%
+57.5%
Q1 2015$3,190,00035,0000.33%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2015
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders